Second UK health body drops Israeli drug firm after activist pressure
Summary
Two major UK health organizations, the Royal College of Nursing and the Royal College of Pharmacy, have ended sponsorship deals with Teva UK, an Israeli pharmaceutical company. These decisions followed pressure from pro-Palestine campaigners and concerns about the company’s activities, alongside Teva's recent legal fines for anti-competitive practices.Key Facts
- The Royal College of Pharmacy canceled Teva UK’s sponsorship and exhibition at its annual conference.
- The Royal College of Nursing dropped Teva as a sponsor of nursing events and its union.
- Both decisions came after reviews flagged Teva’s activities as not aligned with these bodies’ values.
- Pro-Palestine activists influenced the move by circulating an open letter urging ethical scrutiny of partnerships related to Israel.
- Teva specializes in generic drugs and has faced large fines for blocking competition and price fixing.
- The European Commission fined Teva €462.6 million in 2024 for anti-competitive practices with its multiple sclerosis drug.
- In 2023, Teva paid $225 million to settle US Department of Justice charges related to drug price fixing.
- Campaigners want other UK medical royal colleges to also cut ties with Teva.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
